These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. The immune deficiency of chromosome 22q11.2 deletion syndrome. Morsheimer M; Brown Whitehorn TF; Heimall J; Sullivan KE Am J Med Genet A; 2017 Sep; 173(9):2366-2372. PubMed ID: 28627729 [TBL] [Abstract][Full Text] [Related]
29. Early development of immunity in diGeorge syndrome. Sedivá A; Bartůnková J; Zachová R; Poloucková A; Hrusák O; Janda A; Kocárek E; Novotná D; Novotná K; Klein T Med Sci Monit; 2005 Apr; 11(4):CR182-7. PubMed ID: 15795698 [TBL] [Abstract][Full Text] [Related]
30. Lymphocyte Apoptosis and FAS Expression in Patients with 22q11.2 Deletion Syndrome. Aresvik DM; Øverland T; Lima K; Pettersen RD; Abrahamsen TG J Clin Immunol; 2019 Jan; 39(1):65-74. PubMed ID: 30569262 [TBL] [Abstract][Full Text] [Related]
31. Relationship Between Severity of T Cell Lymphopenia and Immune Dysregulation in Patients with DiGeorge Syndrome (22q11.2 Deletions and/or Related TBX1 Mutations): a USIDNET Study. Deshpande DR; Demirdag YY; Marsh RA; Sullivan KE; Orange JS; J Clin Immunol; 2021 Jan; 41(1):29-37. PubMed ID: 32949294 [TBL] [Abstract][Full Text] [Related]
32. Selective IgM deficiency and 22q11.2 deletion syndrome. Kung SJ; Gripp KW; Stephan MJ; Fairchok MP; McGeady SJ Ann Allergy Asthma Immunol; 2007 Jul; 99(1):87-92. PubMed ID: 17650836 [TBL] [Abstract][Full Text] [Related]